Showing results (1-10 of 489) with videos related to
Sort By:
Pageof 49
Clinical Pharmacology and Therapeutics|November 13, 2025
Strategy for Identifying Rational Sensitivity Analysis Using PBPK Modeling for Precipitant Drug-Drug Interaction PredictionsKunal S Taskar, Pradeep Sharma, Karen Rowland YeoEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 4, 2019
Assessing pharmacokinetic differences in Caucasian and East Asian (Japanese, Chinese and Korean) populations driven by CYP2C19 polymorphism using physiologically-based pharmacokinetic modellingLi Zhou, Pradeep Sharma, Karen Rowland Yeo, et al.Journal of Pharmacokinetics and Pharmacodynamics|April 4, 2025
Advancing inclusive healthcare through PBPK modelling: predicting the impact of CYP genotypes and enzyme ontogenies on infant exposures of venlafaxine and its active metabolite O-desmethylvenlafaxine in lactationXian Pan, Karen Rowland YeoClinical Pharmacology and Therapeutics|April 20, 2023
Physiologically Based Pharmacokinetic Modeling to Determine the Impact of CYP2B6 Genotype on Efavirenz Exposure in Children, Mothers and Breastfeeding InfantsXian Pan, Karen Rowland YeoCPT: Pharmacometrics & Systems Pharmacology|February 25, 2023
PBPK modeling of ivermectin-Considerations for the purpose of developing alternative routes to optimize its safety profileKaren Rowland Yeo, David WescheJournal of Cardiovascular Risk|October 24, 2002
Coronary risk versus cardiovascular risk for treatment decisions in mild hypertensionWilfred W Yeo, Karen Rowland YeoEuropean Journal of Clinical Pharmacology|January 20, 2012
Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2David R Plowchalk, Karen Rowland YeoJournal of Hypertension|October 3, 2002
Should we treat high-normal blood pressure?Karen Rowland Yeo, Wilfred W YeoBiopharmaceutics & Drug Disposition|March 24, 2021
When special populations intersect with drug-drug interactions: Application of physiologically-based pharmacokinetic modeling in pregnant populationsCaroline Sychterz, Aleksandra Galetin, Kunal S TaskarCurrent Drug Metabolism|January 5, 2021
Physiologically-based Pharmacokinetic (PBPK) Modelling of Transporter Mediated Drug Absorption, Clearance and Drug-drug InteractionsKunal S Taskar, Isobel Harada, Ravindra V AlluriPageof 49